Candel Therapeutics Inc (CADL)

03:10 AM

Candel eyes 2026 U.S. filing for CAN-2409 after Phase 3 success and FDA RMAT status - Proactive financial news

03:10 AM

12:35 PM

Candel Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener

12:35 PM

11:20 AM

Small cap wrap: Lancaster Resources, Candel Therapeutics, atai Life Sciences, Charbone Hydrogen... - Proactive financial news

11:20 AM

08:50 AM

Candel Therapeutics advances toward prostate cancer therapy filing after trial success - Proactive financial news

08:50 AM

08:22 AM

Candel Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times

08:22 AM

08:13 AM

Candel Therapeutics, Inc. SEC 10-Q Report - TradingView

08:13 AM

Aug 13, 2025

Can Candel Therapeutics Inc. be recession proofJuly 2025 Sentiment & Low Drawdown Investment Strategies - classian.co.kr

Aug 13, 2025

Aug 13, 2025

Can Candel Therapeutics Inc. grow without dilutionWeekly Gains Report & Long Hold Capital Preservation Plans - newsyoung.net

Aug 13, 2025

Aug 11, 2025

Candel Therapeutics Inc. Stages Intraday Comeback — Trend ChangeReal Trader Watchlist of Hot Stocks Released - beatles.ru

Aug 11, 2025

Aug 09, 2025

Candel Therapeutics CADL 2025Q2 Earnings Preview Downside Ahead on Lack of Revenue Data - AInvest

Aug 09, 2025

Aug 08, 2025

Candel Therapeutics Inc. Matches Institutional Buying FilterAI Driven Buy Alert Trade Blueprint Released - beatles.ru

Aug 08, 2025

Aug 07, 2025

Cancer Vaccines Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Dendreon Pharma, Candel Therapeutics, GlaxoSmithKline, Merck, Aduro Biotech, Astrazeneca Plc, Dendreon - The Globe and Mail

Aug 07, 2025

Aug 07, 2025

Candel Therapeutics Institutional Ownership Soars to 44%: Implications for Stock Price Sensitivity - AInvest

Aug 07, 2025

Aug 06, 2025

Candel Therapeutics shares fall 2.76% intraday after announcing clinical trial initiation for tecarfarin in dialysis patients. - AInvest

Aug 06, 2025

Aug 03, 2025

How strong is Candel Therapeutics Inc. company’s balance sheetAchieve explosive financial results today - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are the latest earnings results for Candel Therapeutics Inc.Achieve consistent double-digit growth - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are Candel Therapeutics Inc. company’s key revenue driversCapitalize on market trends early - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is it the right time to buy Candel Therapeutics Inc. stockMaximize profits with strategic stock selection - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How many analysts rate Candel Therapeutics Inc. as a “Buy”Dynamic investment growth - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What catalysts could drive Candel Therapeutics Inc. stock higher in 2025Phenomenal returns - Jammu Links News

Aug 03, 2025

Aug 02, 2025

Candel Therapeutics Inc. Stock Analysis and ForecastUnlock powerful portfolio management tools - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Is Candel Therapeutics Inc. stock overvalued or undervaluedFree Technical Analysis Support - Jammu Links News

Aug 02, 2025

Aug 02, 2025

What makes Candel Therapeutics Inc. stock price move sharplyGain the edge with real-time market data - Jammu Links News

Aug 02, 2025

Aug 01, 2025

Is Candel Therapeutics Inc. a growth stock or a value stockFree Stock Data Feed Backed By Experts - jammulinksnews.com

Aug 01, 2025

Jul 31, 2025

Candel Therapeutics (CADL) Upgraded to Strong Buy: Here's What You Should Know - MSN

Jul 31, 2025

Jul 31, 2025

Applying Wyckoff theory to Candel Therapeutics Inc. stockTop Gaining Picks With Entry Signals Identified - metal.it

Jul 31, 2025

Jul 30, 2025

Candel Therapeutics CMO Garrett Buys, Sells Shares Amid Company's Market Performance. - AInvest

Jul 30, 2025

Jul 30, 2025

Candel Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire

Jul 30, 2025

Jul 30, 2025

Why Candel Therapeutics Inc. stock attracts strong analyst attentionMomentum Based Equity Trading Plans Reviewed - beatles.ru

Jul 30, 2025

Jul 30, 2025

Candel Therapeutics to share company update at Canaccord Genuity Growth Conference - Proactive financial news

Jul 30, 2025

Jul 30, 2025

Candel Therapeutics CEO Dr. Tak to Share Cancer Immunotherapy Progress at Major Growth Conference - Stock Titan

Jul 30, 2025

Jul 29, 2025

Is Candel Therapeutics Inc. Stock a Good Fit for Conservative InvestorsAI Driven Buy Alert Trade Blueprint Released - metal.it

Jul 29, 2025

Jul 29, 2025

Published on: 2025-07-29 16:45:46 - metal.it

Jul 29, 2025

Jul 28, 2025

What machine learning models say about Candel Therapeutics Inc.Swing Trading Entry Signals Suggest Opportunity Zone - metal.it

Jul 28, 2025

Jul 28, 2025

Options Data Show Bullish Bias in Candel Therapeutics Inc.High Conviction Intraday Stock Signals Detected - beatles.ru

Jul 28, 2025

Jul 28, 2025

How does Candel Therapeutics Inc. generate profit in a changing economyNavigate market shifts with confidence - jammulinksnews.com

Jul 28, 2025

Jul 27, 2025

What is Candel Therapeutics Inc. company’s growth strategyExceptional market positioning - Jammu Links News

Jul 27, 2025

Jul 27, 2025

Will Candel Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsTechnical Breakout List - metal.it

Jul 27, 2025

Jul 27, 2025

What is the dividend policy of Candel Therapeutics Inc. stockAchieve consistent profits with proven methods - Jammu Links News

Jul 27, 2025

Jul 27, 2025

What are the technical indicators suggesting about Candel Therapeutics Inc.Massive profits - jammulinksnews.com

Jul 27, 2025